gadolinium oxide has been researched along with chlorogenic acid in 1 studies
| Studies (gadolinium oxide) | Trials (gadolinium oxide) | Recent Studies (post-2010) (gadolinium oxide) | Studies (chlorogenic acid) | Trials (chlorogenic acid) | Recent Studies (post-2010) (chlorogenic acid) |
|---|---|---|---|---|---|
| 178 | 1 | 131 | 3,276 | 76 | 2,241 |
| Protein | Taxonomy | gadolinium oxide (IC50) | chlorogenic acid (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 7.9 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.95 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 1.05 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 0.1 | |
| large T antigen | Betapolyomavirus macacae | 14.67 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad Saad, FF; Fakurazi, S; Hussein, MZ; Masarudin, MJ; Usman, MS | 1 |
1 other study(ies) available for gadolinium oxide and chlorogenic acid
| Article | Year |
|---|---|
A bimodal theranostic nanodelivery system based on [graphene oxide-chlorogenic acid-gadolinium/gold] nanoparticles.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Chlorogenic Acid; Contrast Media; Drug Screening Assays, Antitumor; Gadolinium; Gold; Graphite; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Imaging; Metal Nanoparticles; Mice; Microscopy, Electron, Transmission; Nanocomposites; Oxides; Surface Properties; Temperature; Theranostic Nanomedicine; X-Ray Diffraction | 2018 |